Emerging nanotechnology based combination therapies of taxanes for multiple drug resistant cancers.
Sign Up to like & getrecommendations! Published in 2021 at "Pharmaceutical development and technology"
DOI: 10.1080/10837450.2021.2009861
Abstract: 'One drug- one target' to 'multiple drug- multiple targets' paradigm shifted to produce combination therapies, has found great outcomes to overcome multiple drug resistance (MDR). MDR is a significant barrier to the delivery of taxane… read more here.
Keywords: therapies taxanes; combination therapies; multiple drug; drug ... See more keywords